Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: NDoC Pacers

Did you read HTC's response?

Of course, they see it differently.

TPL’s motion is little more than an improper and disingenuous attempt to deprive this Court of access to the ID prior to ruling on HTC's summary judgment motions. TPL’s motion should be denied in its entirety.

Dated: September 12, 2013 Respectfully submitted,

COOLEY LLP

Share
New Message
Please login to post a reply